Congrats Senior MGt

anonymous

Guest
Congratulations Senior Management, your skills are now officially equal to those who lead Enron.

It’s amazing to think back of the absolute arrogance Senior Management has carried themselves with while they crushed the value of the company with mismanagement. A value of $7 Billion to less than $500 million. Current value $477 million. Inter day stock price of $5.17.

I hear ARD sales reps and Managers not performing will be put on performance plans even though it’s lack of foresight with pricing and payer strategy that has caused the whole problem.

How about a performance plan for senior management.
 






Congratulations Senior Management, your skills are now officially equal to those who lead Enron.

It’s amazing to think back of the absolute arrogance Senior Management has carried themselves with while they crushed the value of the company with mismanagement. A value of $7 Billion to less than $500 million. Current value $477 million. Inter day stock price of $5.17.

I hear ARD sales reps and Managers not performing will be put on performance plans even though it’s lack of foresight with pricing and payer strategy that has caused the whole problem.

How about a performance plan for senior management.
 






It is not the SLT at fault it is the BOD. How can BOD allow these people to keep destroying shareholder value and building massive goodwill! Proud Radiology company that lost its way due to Tyco and current SLT team enabled by BOD. Hope MNK survives and prospers in the future!
 












What could management have done differently?
Contracted with the payers for Acthar with a reasonable price and made up the revenue difference in volume.

Instead they jacked the price way up and reimbursed volume hs crashed.

Collaboration is the future of medicine between all branches. Mallinckrodt shoved pricing down the payers throats with LMNs and P2Ps.
 


















Contracted with the payers for Acthar with a reasonable price and made up the revenue difference in volume.

Instead they jacked the price way up and reimbursed volume hs crashed.

Collaboration is the future of medicine between all branches. Mallinckrodt shoved pricing down the payers throats with LMNs and P2Ps.

Lower the price!
 
  • Like
Reactions: Anonymys






Mallinckrodt is what we legacy folks thought all along.... a generic company!
I remember Hugh’s first speech after acquiring Acthar about how they would change the reimbursement situation around. Right after he said that, he mentioned exploring a buy and bill model. That’s when we knew we were doomed.